Effects of high doses of selenium, as sodium selenite, in septic shock patients a placebo-controlled, randomized, double-blind, multi-center phase II study - Selenium and sepsis

Journal of Trace Elements in Medicine and Biology

Volumn 21, Issue SUPPL. 1, 2007, Pages 62-65

  Forceville, Xavier ^a  

^a CENTRE HOSPITALIER DE MEAUX   (France)

Author keywords

Anti oxidant; Oxidant; Selenium; Septic shock; Sodium selenite

Indexed keywords

PLACEBO; SELENOPROTEIN P; SODIUM SELENITE;

ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; HUMAN; MORTALITY; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SEPTIC SHOCK; UNSPECIFIED SIDE EFFECT; VASCULAR ENDOTHELIUM;

ANIMALIA;

EID: 36248985720     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtemb.2007.09.021     Document Type: Article

References (28)

1. Forceville X. Seleno-enzymes and seleno-compounds: the two faces of selenium. Crit Care 10 (2006) 180
2. Rayman M.P. The importance of selenium to human health. Lancet 356 (2000) 233-241
3. Forceville X., and Vitoux D. Selenium et sepsis. Nutr Clin Metabol 13 (1999) 177-186
4. Dellinger R.P., Carlet J.M., Masur H., Gerlach H., Calandra T., Cohen J., et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 (2004) 858-873
5. Heyland D.K., Dhaliwal R., Suchner U., and Berger M.M. Anti-oxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intens Care Med 31 (2005) 327-337
6. Aird W.C. Endothelium as an organ system. Crit Care Med 32 (2004) S271-S279
7. Novelli G.P. Role of free radicals in septic shock. J Physiol Pharmacol 48 (1997) 517-527
8. Crimi E., Sica V., Slutsky A.S., Zhang H., Williams-Ignarro S., Ignarro L.J., et al. Role of oxidative stress in experimental sepsis and multisystem organ dysfunction. Free Radic Res 40 (2006) 665-672
9. Forceville X., Vitoux D., Gauzit R., Combes A., Lahilaire P., and Chappuis P. Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med 26 (1998) 1536-1544
10. Avenell A., Noble D.W., Barr J., and Engelhardt T. Selenium supplementation for critically ill adults. Cochrane Database Syst Rev (2004) CD003703
11. Harrison I., Littlejohn D., and Fell G.S. Distribution of selenium in human blood plasma and serum. Analyst 121 (1996) 189-194
12. Forceville X, Moster V, Vitoux D, Plouvier E, Lahilaire P, Combes A. Early marked selenoprotein p decrease in severe inflammatory and septic patients. In: First international FESTEM congress on trace elements and minerals in medicine and biology: Mai 2001,Venise, Italie; 2001.
13. Forceville X. Selenium and the "free" electron. Selenium - a trace to be followed in septic or inflammatory ICU patients?. Intens Care Med 27 (2001) 16-18
14. Stewart M.S., Spallholz J.E., Neldner K.H., and Pence B.C. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med 26 (1999) 42-48
15. Olson O.E. Selenium toxicity in animals with emphasis on man. J Am Coll Toxicol 5 (1986) 45-69
16. Jeong D.W., Yoo M.H., Kim T.S., Kim J.H., and Kim I.Y. Protection of mice from allergen-induced asthma by selenite: prevention of eosinophil infiltration by inhibition of NF-kappa B activation. J Biol Chem 277 (2002) 17871-17876
17. Nilsonne G., Sun X., Nystrom C., Rundlof A.K., Potamitou Fernandes A., Bjornstedt M., et al. Selenite induces apoptosis in sarcomatoid malignant mesothelioma cells through oxidative stress. Free Radic Biol Med 41 (2006) 874-885
18. Forceville X., Laviolle B., Annane D., Vitoux D., Bleichner G., Korach J.M., et al. Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care 11 (2007) R73
19. Berger MM, Eggimann P, Heyland DK, Chiolero RL, Revelly J-P, Day A, et al. Reduction of nosocomial pneumonia after major burns by trace element supplementation - aggregation of two randomised trials. Crit Care 2006 R, 10:153.
20. Berger M.M. Can oxidative damage be treated nutritionally?. Clin Nutr 24 (2005) 172-183
21. Angstwurm M.W., Engelmann L., Zimmermann T., Lehmann C., Spes C.H., Abel P., et al. Selenium in intensive care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 35 (2007) 118-126
22. Kuklinski B., Buchner M., Schweder R., and Nagel R. [Acute pancreatitis-a "free radical disease"'. Decrease of lethality by sodium selenite (Na2SeO3) therapy]. Zu Gesamte Innere Med 46 (1991) 145-149
23. Zimmermann T., Albrecht S., Kuhne H., Vogelsang U., Grutzmann R., and Kopprasch S. Selenium administration in patients with sepsis syndrome. A prospective randomized study. Med Klin 3 (1997) 3-4
24. Lindner D., Lindner J., Baumann G., Dawczynski H., and Bauch K. [Investigation of anti-oxidant therapy with sodium selenite in acute pancreatitis, a prospective randomized blind trial]. Med Klin (Munich) 99 (2004) 708-712
25. Mishra V., Baines M., Perry S.E., McLaughlin P.J., Carson J., Wenstone R., et al. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr 26 (2007) 41-50
26. Forceville X., Chancerelle Y., Agay D., Ducros V., and Laporte F. At moderatly high level, sodium selenium seems to decrease mortality in lipopolysaccharide rat model. Intens Care Med 30 (2004) S110
27. Kazda A., Brodska H., Valenta J., Vinglerova M., Hendl J., Stach Z., and Slaba I. Selen and ist substitution in critically ill. Crit Care 10 S1 (2006) S79
28. Kiessling A.H., Isgro F., Skuras J.A., Kammerer I., Lehmann A., and Saggau W. Selenium application in intensive care medicine. Intens Care Med 32 S1 (2006) S89